SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-22-299361
Filing Date
2022-12-06
Accepted
2022-12-06 16:02:34
Documents
8

Document Format Files

Seq Description Document Type Size
1 S-3 d376752ds3.htm S-3 283921
2 EX-5.1 d376752dex51.htm EX-5.1 10017
3 EX-23.1 d376752dex231.htm EX-23.1 1653
4 EX-FILING FEES d376752dexfilingfees.htm EX-FILING FEES 34216
5 GRAPHIC g376752dsp4.jpg GRAPHIC 18651
6 GRAPHIC g376752g07p07.jpg GRAPHIC 73915
7 GRAPHIC g376752g1206103557059.jpg GRAPHIC 1649
8 GRAPHIC g376752g32p32.jpg GRAPHIC 73868
  Complete submission text file 0001193125-22-299361.txt   562986
Mailing Address 40 GUEST STREET BOSTON MA 02135
Business Address 40 GUEST STREET BOSTON MA 02135 617-949-2680
Cue Biopharma, Inc. (Filer) CIK: 0001645460 (see all company filings)

IRS No.: 473324577 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-268687 | Film No.: 221447655
SIC: 2834 Pharmaceutical Preparations